TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | 3 | -2 | -10 | -35 | -28 | -2 | -12 |
| P | %wins | 100 | 50 | 50 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/14/23 16:30 | 8/11/23 | SGTX | Sigilon Therapeutics, Inc. | IN | Health | Drug | Pharmaceutical Preparations | Eli Lilly & Co | IN | T | P | 25,640 | 14.92 | 0 | 1,718 | 0 | D | ||||||||||||||||
12/10/20 17:00 | 12/8/20 | SGTX | Sigilon Therapeutics, Inc. | IN | Health | Drug | Pharmaceutical Preparations | Eli Lilly & Co | IN | T | P.d | 5,400 | 18.00 | 0 | 300 | 12 | 2,744 | D | |||||||||||||||
4/14/16 18:41 | 4/12/16 | AGLE | Aeglea Biotherapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lilly Eli & Co | IN | T | P.d | 5,000 | 10.00 | 5 | 500 | 24 | 2,569 | I | -16 | 2 | -12 | -23 | -50 | -28 | |||||||||
11/12/14 11:50 | 11/12/14 | CHRS | Coherus Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lilly Eli & Co | IN | H | Former 1 | P.d | 2,227 | 13.50 | 0 | 165 | 6 | 3,042 | D | ||||||||||||||
4/15/14 20:41 | 4/15/14 | CERU | Cerulean Pharma Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lilly Eli & Co | IN | T | P.d | 5,134 | 7.00 | 3 | 733 | 45 | 2,356 | I | 4 | 8 | 4 | -19 | -28 | -2 | |||||||||
11/21/13 17:23 | 5/14/13 | RCPT | Receptos, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lilly Eli & Co | IN | T | P.ad | 2,000 | 14.00 | 0 | 143 | 7 | 2,081 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |